Back to PRIMECAP MANAGEMENT CO/CA/ PRIMECAP MANAGEMENT CO/CA/

NKTRNKTR
Showing 8 of 31 quarters

Position history for PRIMECAP MANAGEMENT CO/CA/PRIMECAP MANAGEMENT CO/CA/'s holdings in Nektar Therapeutics

PRIMECAP MANAGEMENT CO/CA/ holds 272,850 shares of NKTR (Nektar Therapeutics), worth $19M as of 2026-Q2. The position was decreased (-2.3% shares). NKTR represents 0.0% of PRIMECAP MANAGEMENT CO/CA/'s portfolio.

Current Value

$19M

Current Shares

272,850

Total Value Change

+$11.4M

Total Shares Change

-5.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
272,850
-2.3%
$19M0.0%$69.81
0
2026-Q1
Decreased
279,150
-0.4%
$20.1M0.0%$68.11
0
2025-Q4
Decreased
280,150
-3.1%
$11.8M0.0%$41.90
0
2025-Q3
Decreased
289,050
-3.6%
$16.4M0.0%$58.92
0
2025-Q2
Decreased
299,718
-94.4%
$7.7M0.0%$25.76
0
2025-Q1
Decreased
5.4M
-3.4%
$3.6M0.0%$11.10
0
2024-Q4
Decreased
5.5M
-6.3%
$5.2M0.0%$14.10
0
2024-Q3
Decreased
5.9M
-1.8%
$7.7M0.0%$17.55
0

Other major holders of NKTR: BNP PARIBAS FINANCIAL MARKETS, Invesco Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used